International Journal of Technology Assessment in Health Care

Article	Citations
PP114 The Influence Of Implicit Factors On The Health Technology Assessment Deliberative Process: A Survey In Five European Countries	57
PP150 The Role Of Expert Consensus In UK Guidance: Patient Selection For Hydrogel Spacer Use During Prostate Cancer Radiotherapy	37
PP53 Applying The VALIDATE Approach To Frame The Assessment Of Integrated Care Management In Aortic Valve Stenosis	28
PP97 Recommendations For Generating South African Health-Related Quality Of Life Data For Cost-Utility Analyses	26
PD35 Mortality And Risk Factors Associated With Dialysis Patients With COVID-19 In A Brazilian Supplementary Health Service	25
PD09 Comparing Long-term Costs Associated With Intraocular Lens Selection And Nd:YAG Laser Capsulotomy In The UK: A Cost-Consequence Analysis	24
OP42 Increasing Access To Real-World Data To Move From Health Technology Assessment To Health Technology Management	23
PP47 Modelling Non-small Cell Lung Cancer Treatment: Predicted and Observed Impact Of Immunotherapy In The Netherlands	23
PP23 Lost In Translation? The Differences In The Use Of Real-World Evidence Across Key Markets	21
OP92 Impact Of Real-World Evidence On Health Technology Assessment And National Guidance For Interventional Procedures: A UK Perspective	20
OP128 Uncertainties In The Cost-Effectiveness Analysis Of Onasemnogene Abeparvovec For Spinal Muscular Atrophy Type 1	18
PP97 How Health Technology Agencies Estimate Target Population Size For Medical Devices: The Example Of Spinal Cord Stimulation	18
PP11 Patient Involvement In Drug Evaluations To Inform Funding Decisions: A Singapore Case Study	16
PP38 Designing A Training And Capacity Building Pathway In Patient Involvement	15
PP105 Efficacy, Effectiveness And Safety Of Letermovir For Prophylaxis Of Cytomegalovirus Infection And Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation	15
PP79 Publication Trends Of Network Meta-analyses In Europe And Asia: A Focus On Cardiovascular Disease	14
Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injury	13
OP60 Methodological Guidance And Doctrine Of The French National Authority For Health For Economic Evaluation	13
OP19 Exploring The Environment/Capacity Of South African Citizen Actors To Contribute To Health Technology Assessment Processes, Policy Development And Institutionalization	13
PP56 National Immunization Technical Advisory Groups Are Essential For Successful Implementation Of The European Health Technology Assessment Regulation	11
PD208 Optimal Scheme For Molecular Diagnosis Of BRCA1/2 Gene Mutations In Patients With Breast Cancer In Poland - Cost-Utility Analysis	11
OP76 Cost-Effectiveness Of Offering Human Papillomavirus Self-Sampling To Non-Attendees Of Organized Primary Cervical Cancer Screening In Germany	11
PD137 Reviewing The Health Technology Assessment And Regulatory Policy Landscape On Acceptability Standards For Real-World Evidence - Initial Findings	11
PD149 Comparison Of The Draft European Union Health Technology Assessment Template With Germany’s AMNOG Template	11
PP07 One Bad Apple Can Spoil The Barrel: Are We Effectively Evaluating Software As A Medical Device?	10

PD129 Extension Of An Influenza Vaccination Program To Include Those Aged 50 To 64 Years: A Rapid Health Technology Assessment Approach	10
PD10 Cost Effectiveness Analysis Of Etranacogene Dezaparvovec Versus Factor IX Prophylaxis In Adult Men With Hemophilia B From Brazil	9
OD12 Large Language Models As Powerful Tools In Health Technology Assessment	9
Health technology assessment in traditional and complementary medicine: a scoping review of international activity and examples of acupuncture	8
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	8
PP92 Enhancing Patient Engagement In Health Technology Assessment: Identification Of Barriers, Facilitators, And Proposals For Improvement	8
Trust, validation, and accountability: implementing uses of generative artificial intelligence into Health Technology Assessment practice	8
Reframing early health technology assessment through a lifecycle lens: Commentary on “defining early health technology assessment: building consensus using Delphi technique”	8
OP25 Rapid Molecular Tests For Detecting Multidrug-Resistant Microorganisms: An Overview Of Systematic Reviews Within A Living Evidence Project	8
From HTA to the Bedside: Aligning GenAI Validation with Clinical Reality	8
Development and implementation of a value framework for rapid health technology assessment reports: enhancing evidence-informed decision making in resource-constrained settings	8
Mapping frameworks for synthesizing qualitative evidence in health technology assessment	7
PD33 Exploring The Influence Of Patient Preference Information In Health Technology Assessment: Insights From Mock Deliberations With Agencies	7
Considering research waste in economic evaluations of low-dose CT screening for lung cancer	7
PP86 Cost Effectiveness Of Maternal Respiratory Syncytial Virus (RSV) Prefusion F (RSVpreF) With Complementary Nirsevimab Versus Nirsevimab Alone For Preventing RSV Among Infants In Chile	7
PP36 Comparing Artificial-Intelligence-Generated And Expert-Driven Chemotherapy Recommendations For Node-Positive Breast Cancer	7
Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum	7
OP66 Assessment Of Patient And Public Involvement Reporting In Health Technology Assessment Documents In Brazil (2023 To 2024)	7
OP82 Positron Emission Tomography Combined With Computed Tomography Using 18F-Sodium Fluoride	7
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report	7
OP90 Optimizing Health Technology Assessment And Appraisal For Orphan Drug Reimbursement: Experiences And Tools For Improvement	6
PD203 Comparison Of Health Technology Assessment Methodologies Across Australia, Canada, New Zealand And The United Kingdom: Implications For Future Collaboration	6
PP149 A Multidimensional And Multistakeholder Approach: Assessing Ethical, Legal, Organizational, Social or Patient-centered (ELSI+) for Telemedicine In Neurological Diseases	6
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	6
OP80 Generating Patient Preference Evidence For Health Technology Assessment: A Sustainable Roadmap	6
PP118 Cyclic Mental Health Technology Assessment with Priority Setting And Involving Stakeholders - A Case Report From The Netherlands	6
A first exploration of the economic consequences of an autonomous surgical robot for lateral skull base surgery: an early health technology assessment	6
The role of health economics within health technology assessment: past, present, and future – an Austrian perspective	6
PP09 Use Of Real-World Evidence For Managing Health Technologies Throughout The Life Cycle Of Transcatheter Aortic Valve Interventions	6
OD11 Application Of Natural Language Processing To Predict Final Recommendation Of Brazilian Health Technology Assessment Reports	5
PP146 Seeing Eye-To-Eye on Real-World Evidence: Are Guidance from Japan and China Consistent with Recommendations from REALISE in Asia?	5
PD71 Survival Outcomes And Adherence To Defined Daily Doses Of Imiglucerase: A 16-Year Brazilian Cohort Study In Gaucher Disease	5
Organizational impact in healthcare in France: a decade of insights but chicken and egg situation	5
OP176 Integrating Real-world Compliance In The Assessment Of Left Atrial Appendage Closure Versus Anticoagulation Therapy In Non-valvular Atrial Fibrillation	5
PP09 Fecal Immunochemical Tests For Patients With Symptoms Suggestive Of Colorectal Cancer: A Systematic Review And Multiple-Threshold Meta-Analysis	5
OP27 Impact Of Generic Entry Of Pharmaceuticals On Drug Prices In Australia	5
Perception of non-layperson advisory committee members on the application of a discrete choice experiment instrument to patients and advisory committee members: a qualitative study	4
OP167 An Analysis Of Medication Exclusion Reports In The Health Technology Assessment Process For The Brazilian Unified Health System	4
A value framework for lymphoma therapies based on MACBETH method	4
PP13 Access Barriers After The Incorporation Of Technologies Into The Unified Health System In Brazil	4
Acknowledgements	4
OP62 Trends In Uncertainties And Outcomes Following An Assessment Of Cancer Topic Suitability For The Cancer Drugs Fund	4
Results of health technology assessments of orphan drugs in Germany—lack of added benefit, evidence gaps, and persisting unmet medical needs	4
OP46 The Decision Uncertainty Toolkit: Risk Measures And Visual Outputs To Support Health Technology Decision-making During Public Health Crises	4
A review of HTA guidelines on societal and novel value elements	4
The HTAi early HTA definition: a welcome milestone, and what must follow	4
PD75 Evolution Of Health Technology Submissions In The Unified Health System: Analysis Of National Committee For Health Technology Incorporation (CONITEC) Evaluations (2012 to 2024)	4
OP63 Life Cycle Health Technology Assessment: Brazil’s Experience With CONITEC	4
OP08 A Comprehensive Collaborative Framework To Enhance Orphan Drug Accessibility For Rare Diseases: Insights From Türkiye	4
OP126 Clinical And Economic Evaluation Of The Effectiveness Of Cerebrolysin® In Neurological Patients With Post-Stroke Complications In Kazakhstan	4

Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology	4
PP54 Next Generation Sequencing Gene Panel For Medical Lung Cancer Medical Care	4
OP17 Updated Cost-Effectiveness Threshold Estimates For 174 Countries Based On Projected Growth In Life Expectancy, Health Expenditure, And Gross Domestic Product	4
PD32 Opportunities And Challenges: Health Technology Assessment Body Perspectives On The Integration Of Artificial Intelligence In Evidence Synthesis	4
Unveiling trends: insights into medicines reimbursement recommendations and health technology management in Ireland (2018–2023)	4
OP136 A Comparison Of Health Technology Assessment Recommendations In Australia, Canada, And England: Is There Opportunity For Further Alignment?	3
OP105 Gaps, Challenges And Priorities For Neurodegenerative Disease Research And Health Technology Assessment	3
OP51 Use Of Real-World Data In Cost-effectiveness Analysis Of Sequential Biologic Treatment For Rheumatoid Arthritis	3
The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey	3
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders’ perspectives	3
PP42 Comprehensive Care Program For Polypharmacy Patients: Cafam Experience (Healthcare Provider Institution – Pharmaceutical Manager)	3
PD68 Access To Medications For Chronic Degenerative And Rare Diseases In The Brazilian Public Health System: 2012 to 2023	3
PD05 Novel Non-Thermal Ablation Technology For The Treatment Of Atrial Fibrillation	3
Toward including environmental sustainability in Health Technology Assessment	3
OP44 Does The Health Economic Modelling Structure Matter? An External Validation Of Three Approaches Commonly Used In Obesity Modelling	3
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities	3
Patient-based evidence: its role in decision making on end-of-life, orphan, and ultra-orphan medicines	3
OP65 An Overview Of Participatory Approaches, Stakeholders, Methods, Topics and Challenges In Medical Device Development: A Scoping Review	3
PP39 Monitoring Clinical Trial Registers In The Context Of A Systematic Review On Vitamin D For COVID-19	3
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data	3
PP111 Reimbursement And Payment Models: A Survey Of Stakeholders’ Current Experiences And Future Outlook Within The Dutch Policy Setting	3
OP163 Applying A Local Economic Evaluation Framework To Make Evaluations More Relevant For Local Decision Makers	3
Building capacity in horizon scanning, early awareness, and disinvestment: a framework for education and training	3
Health technology assessment and healthcare environmental sustainability: Prioritizing effort and maximizing impact	3
PP70 Mapping Of Health Technology Assessment In China: A Comparative Study Between 2016 And 2021	3
PD22 Exploratory Analysis of a Brazilian Real-World Open Database Applied to Prostate Cancer	3
OP50 BRISA: Regional Database Of Health Technology Assessment Reports Of The Americas	3
A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK	2
PD177 The Effect Of COVID-19 On Cancer Screening In Brazil, Canada, And The USA: A Cross-National Study	2
PD92 Procedures For Disinvestment Of Health Technologies In Latin America	2
PP34 Impact Of The COVID-19 Pandemic On Depression Incidence And Healthcare Service Use Among Patients With Depression	2
Acceptability of self-administered antigen test for COVID-19 in the Philippines	2
PD96 Are Continuous Noninvasive Blood Pressure Monitoring Devices Accurate Enough To Replace Invasive Monitoring? A Rapid Review	2
PP87 Glecaprevir/pibrentasvir (Maviret®) Remains A Cost-effective Treatment For Chronic Hepatitis C Virus Infection After Changes To The Treated Population	2
PP41 COVID-19 Modeling To Support Decision Making In Brazil: A Scoping Review	2
OP01 Impact Of Cost Heterogeneity On Assessing The Value Of Gene Therapies	2
PP33 Molecular Markers For The Detection Of Clinically Significant Prostate Cancer	2
PP55 Health Technology Assessment Scoping Definition For Health Regulation	2
Patient perspectives on continuous glucose monitoring system (CGMS) for diabetes in Malaysia: a vital voice in health technology assessment (HTA) informing decision-making	2
OD14 Harmonization Of HTA For Digital Health Technologies: The EU-Funded European Digital Health Technology Assessment Project	2
PD07 Cost-Effectiveness Of Direct Oral Anticoagulants In Chinese Patients With Non-Valvular Atrial Fibrillation	2
OP70 Implementation Of An Online Consultation Hub To Facilitate Consumer Engagement In Health Technology Assessment Processes	2
PD57 Drugs For Chronic Degenerative And Rare Diseases In The Brazilian Public Health System: Profile Of Budget Impact Analyses	2
PP51 Critical Analysis Of Budget Impact Analyses For Health Technologies In The Brazilian Supplementary Health System	2
PP37 Guidance On Using Hospital-Based Real-World Evidence In Health Technology Assessments For Oncology	2
OD33 Assessment Tool For MHealth Apps To Manage Depression (EvalDepApps Project)	2
Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum	2
PP129 Health Technology Assessment Adaptation: Pharyngolaryngeal Biopsies (OLB) For People with Suspected Head and Neck Cancer in the Outpatient Setting	2
Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia	2
PD199 Global Collaboration Post-Brexit: Do Project Orbis And The Access Consortium Improve Access In The UK Compared With Europe?	2
The role of financial distress as a patient-relevant endpoint in early benefit assessments for oncology drugs: a mixed-methods document analysis	2
PD124 Genicular Artery Embolization For The Treatment Of Knee Osteoarthritis: A Systematic Review And Meta-analysis	2
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment	2
PP57 Outcomes Model For Assessing Strategies Improving In Vitro Fertilization Birth Rates	2
OD39 Evaluation Of Sustainability And Environmental Impact Measures In Health Technology Assessment Of Medical Technologies In Europe: Starting An Important Journey	2
OP72 Clinical And Economic Impact Of The Availability Of Innovative Therapies For Advanced Lung Cancer In Latin America	2
PD186 Treat-To-Target In Gout: Are Private General Practitioners In Malaysia Riding The Evidence-Based Wave?	2
PD119 Interventions To Improve Long COVID Symptoms: A Systematic Review Of Randomized Controlled Trials	2
PD50 Does The New Healthcare Reform Improve Job Satisfaction Among Village Clinic Doctors In China? A Meta-Analysis	2
Expanding access to sodium-glucose cotransporter 2 inhibitors (SGLT2i) in the Ministry of Health Malaysia – a multiple HTA approach	2
OP79 Incorporating Environmental Impacts Into Health Technology Assessment: An Examination Of Potential Approaches And Challenges	2
PD133 Exploring Real-World Data Based Financing Models For Lung Cancer Immunotherapy In The Czech Republic	2
PP120 Fluorescent In Situ Hybridization (FISH) Vs Conventional Cytogenetic (CC) For Detecting High-Risk Genetic Mutations In Multiple Myeloma	2
PD42 Should Antibiotics Be Used To Treat Recurrent Otitis Media In Children? Updating A Recommendation	2
Closing the gap: do we need a framework for embedding equity in health technology assessment?	2
PD231 A New Way Of Identifying And Selecting Health Technology Assessment Topics: Using Social Media And Citizen Involvement	2
Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA	2
PP13 Development Of Recommendations And Proposal For A Value-Based Managed Entry Agreement For Italian Setting	1
OD30 Clinician-Driven Health Technology Assessment: National Cancer Medicines Review For Off-Label Uses And On-Label Off-Patent Uses In NHSScotland	1
OP61 Target Trial Emulation To Determine The Population-Level Cost-Effectiveness Of Multigene Panel Sequencing For Advanced Melanoma	1
OP43 Incorporating Mathematical Modeling To Improve Accuracy Of Budget Impact Analysis: Using Screening For Hepatitis C As An Example	1
PP53 Potential Cost-Effectiveness And Innovation Headroom Of A More Accurate Companion Diagnostic For PD-L1 In Non-Small-Cell Lung Cancer	1
PP12 Challenges In Assessing The Efficacy Of Non-Pharmacological Measures In The Context Of The COVID-19 Pandemic	1
PP50 Improving The Evaluation Of Devices And Procedures: Impact Of The National Committee For Health Technology Incorporation Subcommittee	1
PP09 Automated Study Selection Flowchart: Direct_Flow	1
OP47 New Health Technology Assessment Framework For Digital Health Technologies	1
PP14 Value-Based Pricing For Advanced Therapy Medicinal Products: Emerging Affordability Solutions	1
PP108 Multidimensional Analysis Of Peristeen Plus Medical Device	1
PD51 Strategies For Reducing Cesarean Section Rates: An Overview Of Organizational Interventions	1
IOATLAS: scanning across the medical horizon	1

OP98 Improving Patient Involvement In Health Technology Assessments: Is It Enough To Train Just The Patients?	1
Innovating HTA: a call for capacity building and standardization	1
OP20 Technical Validation Of An Environmental Model: A Multidisciplinary Checklist To Guide Environmental Criteria In Health Technology Assessment	1
PD39 First Approach For Assessing Statistical Significance In Industry Funded Matching-Adjusted Indirect Comparison Studies: A Scoping Review	1
OP11 Cost-Effectiveness Of Atezolizumab Plus Chemotherapy As A First-Line Treatment For Metastatic Non-Squamous Non-Small Cell Lung Cancer	1
Level of health technology assessment process-related skills among doctors in Croatia: a cross-sectional survey study	1
OP35 Early Access To Medicinal Products In France: A Positive Evaluation Two Years Into The New Framework	1
OP168 Costs And Effectiveness Of Whole Exome Sequencing (WES) In Patients With Unsolved Rare Disease Through The Diagnostic Pathway	1
Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape	1
OP102 Towards Universal Health Coverage: Health Technology Assessment Roadmap Development In The Emirate Of Abu Dhabi Involving The Whole Ecosystem	1
PD32 Incorporating Environmental Factors Into Health Technology Assessment Submissions: A Scoping Review	1
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France	1
PP60 Literature Review For Health Technology Assessment (HTA)-Based Decision Making In Brazil: Artificial Urinary Sphincter For Post-Prostatectomy Severe Urinary Incontinence	1
PD31 Counting Oncology Patients In The Brazilian Public Health System: A Comprehensive New Methodology	1
PD56 Conceptual Issues In The Valuation Of Health States In Children	1
PP22 A Lifecycle Approach To The Use Of Real-World Evidence In HTA Submissions And Resubmissions: A Decade’s Experience	1
Incorporating healthcare access and equity in economic evaluations: a scoping review of guidelines	1
OP74 Analysis Of Literature And Research Foci In Overdiagnosis Based On Citespace	1
OD26 Comparing Health Technology Developers’ Proposed Indication To An Estimated Indication Generated By An International Horizon Scanning Database	1
OP93 Informing Efficient Diagnostic Monitoring Pathways Using Prospective Cohort Data: A Case Study In Neovascular Age-Related Macular Degeneration	1
OP13 Improving Case Finding For Celiac Disease In Children And Adults: Evidence Synthesis And Economic Modeling	1
PP21 Examining Clinical Evidence: Incorporation Of Medications For Ultra-Rare Diseases – Descriptive Analysis Of Conitec Reports (2012 to 2022) – Brazil	1
Building sustainable health technology assessment capacity in Ukraine	1
PD60 The Importance Of Systematic Reviews Addressing Questions Of Prevalence In Health Technology Assessment	1
OP51 Improving Childhood Cancer Management And Financing In Ghana: Results From Stakeholder Mapping and Analysis	1
OP03 The Distribution Of Quality-Adjusted Life Expectancy By Level Of Socioeconomic Disadvantage And Remoteness Area For The Australian Population	1
OP31 Monitoring Of The Budget Impact Determinants Of Incorporated Technologies For Rare Diseases In The Brazilian Health System	1
Priority setting for health technology adoption at the national level: Lessons learned over 25 years’ experience	1
OP83 Joining Efforts To Improve Patient Involvement In Health Technology Assessment: The Case Of The RedETS Patient Interest Group	1
OP51 Targeted Next-Generation Sequencing Gene Panel In Chronic Lymphocytic Leukemia Medical Care	1
PD21 Evidence Assessment Frameworks And Economic Modeling For Rare Diseases: A Stakeholder Survey Exploring Current Practices In HTA	1
PD32 Cost-Utility Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Chemotherapy-Refractory Metastatic Colorectal Cancer In Brazil	1
OP67 Considerations Of Treatment Novelty In Health Technology Assessment	1
PP28 Leveraging Social Media For Educating Laypeople On Health Technology Assessment: The Participa SUS/ATS Experience	1
PD25 Identification Of Unmet Medical Needs Through A Health Technology Assessment Process To Guide Research And Development: Experience From A University Hospital	1
PP100 Improving The Assessment Of Effectiveness For Digital Applications Using The B Statistic: Using WtsWrng As A Case Study	1
Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report	1
PP30 A Costing Template For The Implementation Of A Public And Patient Advisory Board For Health Research In Dementia	1
OD41 Conducting Systematic Reviews On Rare Diseases: Lessons Learned From The European Reference Networks Guidelines Programme	1
OP88 Translating Patient Reported Measure Score Into Specific Outcomes From The Patient Perspective–Example Using Health Assessment Questionnaire-Disability Index	1
OP69 Are Artificial-Intelligence-Based Literature Reviews Accepted By Health Technology Assessment Bodies?	1
PP43 Budget Impact Analysis Of Next-Generation Sequencing Coverage In Taiwan’s National Health Insurance	1
OP11 Differences And Similarities In Past Health Technology Assessments In Beneluxa Initiative Countries	1
Implementing a sandbox approach in health technology assessment: benefits and recommendations	1
PD65 Pilot Project Of Horizon Scanning To Inform The Ukrainian Health System About New HIV/AIDS Health Technologies	1
PP59 Do Patient Contributions Matter? A Thematic Document Analysis Of NICE Ultra-Rare Disease Appraisals	1
PP84 Evaluation Of The Evidence Level Of Scrambler Therapy For Musculoskeletal Pain Relief: A Systematic Literature Review	1
PD18 Cytomegalovirus Prophylaxis With Valganciclovir For HIV-Immunosuppressed Patients: Cost Effectiveness And Budget Impact Analysis From The Brazilian Healthcare System Perspective	1
PD01 Advances In The Incorporation Of Medical Devices: A Case Study On Technology Developed By A Brazilian University	1
PD93 Uncertainty Metric To Guide PICOS Assessment And Evidence Synthesis Planning For Joint Clinical Assessment Submission	1
OD17 Future Health And Economic Burden Of Cardiovascular Disease In Type 2 Diabetes In Australia From 2021 To 2031	1
OP45 Incorporation Of The Tetravalent Dengue Vaccine In The Brazilian Public Health System: A Cost–Benefit Analysis	1
PP76 Clinical Guidelines For Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis: Incorporating Rituximab To Enhance Equity In Access And Treatment In Brazil	1
PP63 Perspectives Of Physical And Organic Disability Organizations On Health Technology Assessment Processes	1
OP56 Hospital-Based Health Technology Assessment: Barriers And Facilitators In France, Hungary, Italy, Kazakhstan, Poland, Switzerland, And Ukraine	1
PD35 A Decade In Review: Assessing The Quality Of Clinical Evidence For Oncology Drugs Submitted To A National Health Technology Assessment Agency	1
PP24 Creating A Comprehensive Open-Access Health Technology Assessment (HTA) Policy Research Database Through Automated Data Extraction From HTA Reports	1
PP153 The Economic And Fiscal Impact Of Public Health Programs For Diabetic Patients In Italy	1
PD61 Thromboprophylaxis After Major Orthopedic Surgeries: Health Technology Assessment To Promote Access To Oral Anticoagulants	1
National health technology assessment in Turkiye after a decade: are key principles followed?	1
PD17 Next-Generation Sequencing Gene Panel For Gastrointestinal Stromal Tumor Care	1
Response to heterogeneity of tests and platforms in economic evaluations: synthetic model adoption; derivatives of transferable practice	1
The UK early access to medicines scheme: uptake, approvals, and reimbursement	1
OP83 Diagnostic Accuracy And Cost Effectiveness Of Automated Ankle Brachial Pressure Index Measurement For Peripheral Arterial Disease In People With Leg Ulceration	1
PP45 Budget Impact Analysis Of Including Bictegravir/Emtricitabine/Tenofovir Alafenamide In First-Line Antiretroviral Therapy For HIV/AIDS In Chile’s Explicit Health Guarantees	1
OP54 The Early Detection And Warning System ‘SINTESIS-New Technologies’: A Horizon Scanning Experience In Spain	1
PP57 Proposal For Adaptation Of The Pharmaceutical Innovativeness Index Based On Lenacapavir	1
OP81 Do Sustainable Healthcare Principles Inform Guidance Development? An Exemplary Case Study In Respiratory Care	1
OP34 Horizon Scanning A Matter Of Collaboration. A Description Of The Processes Of I-HTS Member Organizations	1
PP82 Environmental Sustainability Assessment Across The Medical Device Life Cycle: Taking The Viewpoint Of Low Resource Settings	1
PP153 Efficacy And Safety of Onasemnogene Abeparvovec For The Treatment Of Patients With Spinal Muscular Atrophy Type 1: Meta-Analysis	1
Health technology assessment for oral health in the past decade: a scoping review	1
OP37 How Can We Make Innovative Payment Schemes Work? Findings Of A European Union Horizon Europe Project	1
PD155 RedETS Horizon Scanning: Impact In The Decision-Making Process	1
OP172 International Collaboration For Translating The Peer Review Of Electronic Search Strategies (PRESS) Checklist: A Harmonized Approach	1
Lifecycle evaluation of medical devices: supporting or jeopardizing patient outcomes? A comparative analysis of evaluation models	1
PD185 Is The Incorporation Of Medications For Ultrarare Diseases In Brazil Predominantly Driven By Costs? A Shift In Paradigm	1
PD173 Semi-Automation Of Systematic Literature Review Title And Abstract Screening Using Text Mining And Classification Techniques	1
The relative importance of severity and rarity criteria in health resource allocation: an umbrella review	1
PP04 Extrapolating Survival Curves In Oncology: Advancing Economic Modeling To Meet Next-Generation Health Technology Assessment Demands	1
PD90 Use Of Medicinal Herbs In Natura By Pregnant Women In The Amazon Region	1
INAHTA member agency stories of engaging, adaptable, and impactful HTA	1
PP87 How Innovative Is The Innovation? Early Experience In Assessing The Innovativeness Of Emerging Medical Technologies In Singapore	1
OD37 How The PICOTS-ComTeC Framework For Digital Health Interventions Can Be Useful For Health Technology Assessment	1
PD116 Development Of A Value Framework For The Appropriate Prescription Of High-Cost Cancer Drugs In A Cancer Center	1
OP35 Suitability Of Preference Methods Across The Medical Product Lifecycle: A Multicriteria Decision Analysis	1
PP109 Which Review Is Right For You? Choosing A Review Methodology	1
PD25 Innovation In Facial Palsy Treatment: The Costs And Benefits Of Telerehabilitation Introduced Into Physical Therapy Pathways	1
OP24 Impact Of Patient Input On Cancer Drug Funding Recommendations In Canada	0
Early access schemes for innovative health technologies: the views of international stakeholders	0
Economic evaluation of remote patient monitoring and organizational analysis according to patient involvement: a scoping review	0
Use of RWD in the assessment of economic evaluations of innovative health products: lessons learned from the French National Authority for health (HAS)	0
Health technology assessment of medicinal products in Greece: a 5-year (2018–2023) review of timelines and productivity	0
Health technology assessment (HTA) readiness in Uganda: stakeholder’s perceptions on the potential application of HTA to support national universal health coverage efforts	0
International overview of health technology assessment training tools and materials for patients and consumers	0